Sotac Pharmaceuticals Limited — Important, 29-10-2024: Financial Result Updates

Sotac Pharmaceuticals Limited's board approved the unaudited standalone and consolidated financial results for the half-year ending September 30, 2024. Standalone revenue reached ₹3,061.42 lakhs, with a profit of ₹211.64 lakhs. Consolidated revenue stood at ₹5,259.47 lakhs, yielding a profit of ₹191.25 lakhs. The board reviewed and endorsed additional financial statements, all of which have been submitted for regulatory compliance. No investor complaints were pending during this period.